Tower Research Capital LLC (TRC) - ACURX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ACURX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$10,646
-9.6%
7,097
+59.7%
0.00%
Q2 2023$11,779
+117690.0%
4,445
+53.8%
0.00%
Q1 2023$10
-16.7%
2,890
-0.2%
0.00%
Q4 2022$12
-99.9%
2,895
-0.2%
0.00%
Q3 2022$9,000
+28.6%
2,902
+65.4%
0.00%
Q2 2022$7,000
-36.4%
1,755
-47.1%
0.00%
Q1 2022$11,000
+175.0%
3,319
+369.4%
0.00%
Q3 2021$4,000
+33.3%
707
+53.0%
0.00%
Q2 2021$3,0004620.00%
Other shareholders
ACURX PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Draper Asset Management, LLC 266,025$873,0000.72%
Patriot Financial Group Insurance Agency, LLC 9,750$32,0000.01%
Semmax Financial Advisors Inc. 1,263$4,0000.00%
TD Waterhouse Canada Inc. 30,000$102,3000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,941$35,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 10,100$33,0000.00%
BlackRock Inc. 16,699$55,0000.00%
Tower Research Capital LLC (TRC) 3,319$11,0000.00%
WELLS FARGO & COMPANY/MN 16$00.00%
View complete list of ACURX PHARMACEUTICALS INC shareholders